An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Amgen Inc. (IR) in Hyderabad, India seeks an IS Analyst to lead the implementation and operation of artwork management systems (ESKO) and integrations with Veeva, SAP, EDF, Workato, and Databricks. You will work across Business and DTI teams to deliver scalable technology solutions and improve ROI.
Strong business analysis and SDLC background are required. The role emphasizes agile delivery, cybersecurity, documentation, and collaboration with global teams, driving innovation within
Career Category Information Systems Job Description ABOUT THE ROLE Role Description: The ideal candidate will have a proven track record in a technology-driven industry. You will be responsible for the implementation of artwork management system, ESKO, into the existing Amgen eco-system with applications like VEEVA, SAP, EDF and integrations through Workato and Databricks while leveraging Tableau for analytics and reporting purposes. By collaborating across different Business and DTI teams you will support the development of a vision for how technology can be leveraged to solve critical business problems, understand the impact of technical solutions on business outcomes and ensure to improve the ROI of investments made. As a successful System Analyst, you will lead the overall operation of development, maintenance, and support of the required IS services and you will develop strong domain knowledge in the assigned area. Manage a suite of custom internal platforms, commercial off-the-shelf (COTS) software, and systems integrations. The ideal candidate will have strong business analysis skills and a technical background in the end-to-end software development lifecycle. The candidate should be a self-starter and have a strong passion for fostering innovation and excellence in the biotechnology industry.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen